Answers are grounded in this paper and cite their sources.
Antigen-presenting cells are a heterogeneous group of cells that are characterized by their functional specialization. Consequently, targeting specific antigen-presenting cell subsets offers opportunities to induce distinct T cell responses. Here we report on the generation and use of nanobodies (Nbs) to target lentivectors specifically to human lymph node-resident myeloid dendritic cells, demonstrating that Nbs represent a powerful tool to redirect lentivectors to human antigen-presenting cell subsets.
No takes yet. Share an insight, caveat, or question.
Goyvaerts et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: